These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16208003)

  • 81. [Recombinant virus assay: a rapid assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates].
    Qin SL; Arendt V; Hemmer R; Schneider F; Wang AX; Sheng RY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):523-6. PubMed ID: 12905778
    [TBL] [Abstract][Full Text] [Related]  

  • 82. In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitors.
    Back NK; van Wijk A; Remmerswaal D; van Monfort M; Nijhuis M; Schuurman R; Boucher CA
    AIDS; 2000 Jan; 14(1):101-2. PubMed ID: 10714580
    [No Abstract]   [Full Text] [Related]  

  • 83. Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms.
    Galli A; Lai A; Corvasce S; Saladini F; Riva C; Dehò L; Caramma I; Franzetti M; Romano L; Galli M; Zazzi M; Balotta C
    J Gen Virol; 2008 Dec; 89(Pt 12):3119-3125. PubMed ID: 19008401
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Molecular targets of anti-HIV-1 triterpenes.
    Huang L; Chen CH
    Curr Drug Targets Infect Disord; 2002 Mar; 2(1):33-6. PubMed ID: 12462151
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Testing time as resistant HIV-1 faces next wave of attack.
    Mellors J
    Lancet; 1999 Jul; 354(9173):135. PubMed ID: 10408499
    [No Abstract]   [Full Text] [Related]  

  • 86. The XIth International Conference on AIDS...new milestones for AIDS research and treatment.
    PI Perspect; 1996 Sep; (No 19):1-2. PubMed ID: 11363896
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Novel recombinant virus assay for measuring susceptibility of human immunodeficiency virus type 1 group M subtypes to clinically approved drugs.
    Covens K; Dekeersmaeker N; Schrooten Y; Weber J; Schols D; Quiñones-Mateu ME; Vandamme AM; Van Laethem K
    J Clin Microbiol; 2009 Jul; 47(7):2232-42. PubMed ID: 19403770
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Genotypic resistance testing in HIV by arrayed primer extension.
    Schanné M; Bodem J; Gerhold-Ay A; Jacob A; Fellenberg K; Kräusslich HG; Hoheisel JD
    Anal Bioanal Chem; 2008 Jul; 391(5):1661-9. PubMed ID: 18202840
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1.
    Lindström A; Albert J
    J Virol Methods; 2003 Jan; 107(1):45-51. PubMed ID: 12445937
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance.
    Duarte HA; Panpradist N; Beck IA; Lutz B; Lai J; Kanthula RM; Kantor R; Tripathi A; Saravanan S; MacLeod IJ; Chung MH; Zhang G; Yang C; Frenkel LM
    J Infect Dis; 2017 Dec; 216(suppl_9):S824-S828. PubMed ID: 29040621
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants.
    Domingo E; Menéndez-Arias L; Quiñones-Mateu ME; Holguín A; Gutiérrez-Rivas M; Martínez MA; Quer J; Novella IS; Holland JJ
    Prog Drug Res; 1997; 48():99-128. PubMed ID: 9204684
    [No Abstract]   [Full Text] [Related]  

  • 92. Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1.
    Althaus CL; Bonhoeffer S
    J Virol; 2005 Nov; 79(21):13572-8. PubMed ID: 16227277
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Different HIV-1 strains found in semen and blood.
    Birchard K
    Lancet; 1998 Oct; 352(9137):1363. PubMed ID: 9802285
    [No Abstract]   [Full Text] [Related]  

  • 94. An enzymatic bioluminescent assay of DNA ligation.
    Jansson V; Jansson K
    Anal Biochem; 2004 Jan; 324(2):307-8. PubMed ID: 14690698
    [No Abstract]   [Full Text] [Related]  

  • 95. Transmitted HIV resistance to first-line antiretroviral therapy in Lima, Peru.
    Soria J; Bull M; Mitchell C; La Rosa A; Dross S; Kraft K; Coombs R; Ticona E; Frenkel L
    AIDS Res Hum Retroviruses; 2012 Apr; 28(4):333-8. PubMed ID: 21819256
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.
    Saravanan S; Vidya M; Balakrishnan P; Kumarasamy N; Solomon SS; Solomon S; Kantor R; Katzenstein D; Ramratnam B; Mayer KH
    J Virol Methods; 2009 Aug; 159(2):211-6. PubMed ID: 19490976
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.
    Beck IA; Crowell C; Kittoe R; Bredell H; Machaba M; Willamson C; Janssens W; Jallow S; van der Groen G; Shao Y; Jacob M; Samuel NM; de Rivera IL; Ngo-Giang-Huong N; Cassol S; Alemnji G; Frenkel LM
    J Acquir Immune Defic Syndr; 2008 Aug; 48(4):418-27. PubMed ID: 18614915
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.
    Jallow S; Kaye S; Schutten M; Brandin E; Albert J; McConkey SJ; Corrah T; Whittle H; Vanham G; Rowland-Jones S; Janssens W
    J Clin Microbiol; 2007 May; 45(5):1565-71. PubMed ID: 17329450
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Oligonucleotide ligation assay for detection of mutations associated with reverse transcriptase and protease inhibitor resistance in non-B subtypes and recombinant forms of human immunodeficiency virus type 1.
    Vega Y; Pérez-Alvárez L; Delgado E; Muñoz M; Casado G; Carmona R; Sierra M; Vázquez de Parga E; Pinilla M; García V; Medrano L; Contreras G; Thomson M; Nájera R
    J Clin Microbiol; 2005 Oct; 43(10):5301-4. PubMed ID: 16208003
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors.
    Beck IA; Mahalanabis M; Pepper G; Wright A; Hamilton S; Langston E; Frenkel LM
    J Clin Microbiol; 2002 Apr; 40(4):1413-9. PubMed ID: 11923366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.